Lakefront Biotherapeutics Reports €13.9M Nine-Month Profit
Lakefront reported a €13.9 million net profit for the nine months of 2026, versus a €461.3 million net loss in 2025. Cash and financial investments totaled €2,183.1 million at September 30; year-end 2026 guidance is at least €2 billion and includes a second €50 million repurchase program.
Lakefront reported nine-month 2026 net profit of €13.9M, versus a €461.3M net loss in 2025. Cash and financial investments were €2,183.1M at September 30, and year-end 2026 guidance is at least €2B, including a second €50M repurchase program.Material DetailsContext by AI AnalystThis is a financial…